Posts Tagged ‘specialty drugs’

Infographic: Specialty Pharmacy Growth Trend

July 5th, 2017 by Melanie Matthews

Much of the growth in the U.S. specialty pharmacy industry can be attributed to healthcare provider-owned pharmacies, according to a new infographic by URAC.

The infographic provides a snapshot of the specialty pharmacy industry trend in hospital systems.

Leveraging Pharmacists to Reduce Cost and Improve Medication Adherence in High-Risk PopulationsWhen it comes to medication management for Medicare beneficiaries, there are more than 25 different factors that can complicate proper use of prescribed medicines—from affordability issues, even among the insured, to fear of a drug’s side effects to potential dangers from high-risk medications or health conditions.

Leveraging Pharmacists to Reduce Cost and Improve Medication Adherence in High-Risk Populations examines Novant Health’s deployment of pharmacists as part of its five-pronged strategy to deliver healthcare value through medication management services.

Get the latest healthcare infographics delivered to your e-inbox with Eye on Infographics, a bi-weekly, e-newsletter digest of visual healthcare data. Click here to sign up today.

Have an infographic you’d like featured on our site? Click here for submission guidelines.

7 Healthcare Movements to Monitor in 2017

January 2nd, 2017 by Patricia Donovan

Add a different caption here.

Growing population base should be a 2017 priority for healthcare organizations, advises Steven Valentine.

In offering a set of guiding principles for 2017 success, Steven Valentine, vice president, Advisory Consulting Services, Premier Inc., outlines seven key areas healthcare executives should monitor in the coming year.

First, we have seen some commercial plans move to risk adjustment payments. This could be helpful or detrimental. We definitely have seen more time spent as health systems have moved to more risk payments, more two-sided models.

Next, a definition of financial responsibility (DoFR) will be critical: knowing all the various benefits that are offered and perhaps listing them on the left side of a spreadsheet. As you move across the sheet, what remains with a health plan, if anything? What would go with the physician organization? What would go to an inpatient facility acute hospital? To ambulatory providers and post-acute providers? We would advise you to begin to move in 2017 to standardize those DoFRs.

Then, if at all possible, exclude specialty drugs, where we’ve seen tremendous price increases. If you can exclude any new kinds of therapies, and I mention one there that’s been popular and growing in 2016, IVIG, and we expect a pretty good jump in 2017. Some doctors have labeled this the ‘feel good infusion.’

Then, determine whether you can do anything on an exclusive basis that would help you capture more population. At the end of the day, strategically, in 2017, you need to grow your population base.

Next is effective use of comanagement agreements and a renewed focus on your risk adjustment factor (RAF) scores: there will be slight adjustments as they go down and you’re going to have to do a better and better job of documenting and trying to push those up.

Then we see patient engagement; we do want to see the patients engaged. The more you use various patient portals, the more helpful it will be.

Finally, we also look at the repatriation of patients, because if you have them under your care, you would be responsible for getting those patients and paying for them.

Source: Healthcare Trends & Forecasts in 2017: Performance Expectations for the Healthcare Industry

Healthcare Trends & Forecasts in 2017: Performance Expectations for the Healthcare Industry, HIN’s thirteenth annual business forecast, is designed to support healthcare C-suite planning during this historic transition as leaders prepare for both a new year and new presidential leadership.